BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26991649)

  • 1. EXTRAMACULAR FIBROSIS IN COATS' DISEASE.
    Daruich A; Matet A; Tran HV; Gaillard MC; Munier FL
    Retina; 2016 Oct; 36(10):2022-8. PubMed ID: 26991649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
    Ramasubramanian A; Shields CL
    Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.
    Li S; Deng G; Liu J; Ma Y; Lu H
    BMC Ophthalmol; 2017 May; 17(1):76. PubMed ID: 28532448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease.
    Zheng XX; Jiang YR
    Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):35-42. PubMed ID: 23873253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment of pediatric coats' disease: a bicenter study in Taiwan.
    Lin CJ; Chen SN; Hwang JF; Yang CM
    J Pediatr Ophthalmol Strabismus; 2013; 50(6):356-62. PubMed ID: 24669373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative fluorescein angiography-guided treatment in children with early Coats' disease.
    Suzani M; Moore AT
    Ophthalmology; 2015 Jun; 122(6):1195-202. PubMed ID: 25824326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUBFOVEAL NODULE IN COATS' DISEASE: Toward an Updated Classification Predicting Visual Prognosis.
    Daruich AL; Moulin AP; Tran HV; Matet A; Munier FL
    Retina; 2017 Aug; 37(8):1591-1598. PubMed ID: 28030429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center.
    Shields CL; Udyaver S; Dalvin LA; Lim LS; Atalay HT; L Khoo CT; Mazloumi M; Shields JA
    Indian J Ophthalmol; 2019 Jun; 67(6):772-783. PubMed ID: 31124485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoschisis in the setting of Coats' disease.
    Yannuzzi NA; Tzu JH; Hess DJ; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):172-4. PubMed ID: 24635161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual outcomes after treatment in pediatric patients with Coats' disease.
    Chiu HH; Wan MJ; Kertes PJ; Muni RH; Lam WC
    Can J Ophthalmol; 2019 Dec; 54(6):647-652. PubMed ID: 31836093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.
    Bhat V; D'Souza P; Shah PK; Narendran V
    Middle East Afr J Ophthalmol; 2016; 23(2):208-11. PubMed ID: 27162454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of stage 3 Coats' disease by endolaser photocoagulation via a two-port pars plana nonvitrectomy approach.
    Cai X; Zhao P; Zhang Q; Jin H
    Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):999-1004. PubMed ID: 25794987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful use of intravitreal ranibizumab injection and combined treatment in the management of Coats' disease.
    Yang Q; Wei W; Shi X; Yang L
    Acta Ophthalmol; 2016 Jun; 94(4):401-6. PubMed ID: 27150442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coats' disease: characteristics, management, outcome, and scleral external drainage with anterior chamber maintainer for stage 3b disease.
    Yousef YA; ElRimawi AH; Nazzal RM; Qaroot AF; AlAref AH; Mohammad M; Abureesh O; Rejdak R; Nowomiejska K; Avitabile T; Toro MD; AlNawaiseh I
    Medicine (Baltimore); 2020 Apr; 99(16):e19623. PubMed ID: 32311932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant anti-VEGF therapy in Coats' disease].
    Fiorentzis M; Stavridis E; Seitz B; Viestenz A
    Ophthalmologe; 2015 May; 112(5):451-4. PubMed ID: 25134462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of intravitreal bevacizumab and pascal laser photocoagulation in the management of adult Coats' disease.
    Raoof N; Quhill F
    Middle East Afr J Ophthalmol; 2013; 20(3):256-8. PubMed ID: 24014992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective photocoagulation in Coats' disease: ten-year follow-up.
    Nucci P; Bandello F; Serafino M; Wilson ME
    Eur J Ophthalmol; 2002; 12(6):501-5. PubMed ID: 12510719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual prognosis of Coats' disease.
    Budning AS; Heon E; Gallie BL
    J AAPOS; 1998 Dec; 2(6):356-9. PubMed ID: 10532724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating Scleral Buckling, Transscleral Drainage of Subretinal Fluid, Intravitreal Anti-Vascular Endothelial Growth Factor, and Laser Photocoagulation in Stage 3B Coats' Total Retinal Detachment.
    Huang YC; Lai CC; Wu WC
    Ophthalmic Surg Lasers Imaging Retina; 2016 Sep; 47(9):865-8. PubMed ID: 27631484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcomes of Total Exudative Retinal Detachments in Stage 3B Coats Disease.
    Li AS; Capone A; Trese MT; Sears JE; Kychenthal A; De la Huerta I; Ferrone PJ
    Ophthalmology; 2018 Jun; 125(6):887-893. PubMed ID: 29361355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.